Stockholders Equity (Tables)

3 Months Ended

Mar. 31, 2023

Stockholders' Equity Note [Abstract]

Schedule of restricted stock awards granted

	Number of Restricted Stock Awards		Weighted Average Grant Day Fair Value
Nonvested at December 31, 2022		3,384		3.16
Granted		—		—
Vested		—		—
Nonvested at March 31, 2023		3,384		3.16

Schedule of stock option plan

	Number of Shares		Weighted Average Exercise Price		Total Intrinsic Value		Weighted Average Remaining Contractual Life (in years)
Outstanding as of December 31, 2022		104,651	$	49.80	$	—		8.3
Employee options issued		—	$	—		—		—
Outstanding as of March 31, 2023		104,651	$	49.80	$	—		8.1
Options vested and exercisable as of March 31, 2023		104,651	$	49.80	$	—		8.1

Schedule of stock-based compensation expense

	Three Months Ended March 31,
	2023		2022
Employee stock option awards	$	—	$	560,375
Non-employee restricted stock awards		1,972		791
Non-employee stock warrant awards		8,658		16,272
	$	10,630	$	577,438

Schedule of warrant activity

	Number of Warrants			Weighted Average Exercise Price		Total Intrinsic Value		Weighted Average Remaining Contractual Life (in years)
Outstanding as of December 31, 2022		402,840		$	49.73	$	—		1.4
Issued		4,460,000			2.94		—		—
Expired		—			—		—		—
Exercised		(1,860,000	)		0.001		—		—
Outstanding as of March 31, 2023		3,002,840			11.04		—		4.83
Warrants exercisable as of March 31, 2023		3,002,840		$	11.04	$	—		4.83